Schuler Jack W's Form 4 filing
Soleno Therapeutics Inc (SLNO) · filed Oct 14, 2022
- Accession no.
- 0001209191-22-053711
- Filed
- Oct 14, 2022
- Trade date
- Aug 2-26, 2022
- Filing delay
- 73 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 18 non-derivative transactions. Open-market sales total $487.7K. It was filed 73 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schuler Jack WCIK 0001021412 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 2, 2022 | Common Stock | SSaleDisposed | −353 | $2.55 | −$900.15 | 646,836 | Indirect | |
| Aug 3, 2022 | Common Stock | SSaleDisposed | −2,520 | $2.54F3 | −$6,400.8 | 644,316 | Indirect | |
| Aug 4, 2022 | Common Stock | SSaleDisposed | −5,103 | $2.46F4 | −$12,553.38 | 639,213 | Indirect | |
| Aug 5, 2022 | Common Stock | SSaleDisposed | −6,696 | $2.52F5 | −$16,873.92 | 632,517 | Indirect | |
| Aug 8, 2022 | Common Stock | SSaleDisposed | −6,824 | $2.64F6 | −$18,015.36 | 625,693 | Indirect | |
| Aug 10, 2022 | Common Stock | SSaleDisposed | −8,006 | $2.65F7 | −$21,215.9 | 617,687 | Indirect | |
| Aug 11, 2022 | Common Stock | SSaleDisposed | −2,675 | $2.72F8 | −$7,276 | 615,012 | Indirect | |
| Aug 12, 2022 | Common Stock | SSaleDisposed | −16,667 | $2.65F9 | −$44,167.55 | 598,345 | Indirect | |
| Aug 15, 2022 | Common Stock | SSaleDisposed | −53,333 | $2.93F10 | −$156,265.69 | 545,012 | Indirect | |
| Aug 16, 2022 | Common Stock | SSaleDisposed | −7,718 | $2.88F11 | −$22,227.84 | 537,294 | Indirect | |
| Aug 17, 2022 | Common Stock | SSaleDisposed | −5,212 | $2.90F12 | −$15,114.8 | 532,082 | Indirect | |
| Aug 18, 2022 | Common Stock | SSaleDisposed | −10,833 | $2.80F13 | −$30,332.4 | 521,249 | Indirect | |
| Aug 19, 2022 | Common Stock | SSaleDisposed | −7,876 | $2.73F14 | −$21,501.48 | 513,373 | Indirect | |
| Aug 22, 2022 | Common Stock | SSaleDisposed | −4,571 | $2.68F15 | −$12,250.28 | 508,802 | Indirect | |
| Aug 23, 2022 | Common Stock | SSaleDisposed | −173 | $2.62F16 | −$453.26 | 508,629 | Indirect | |
| Aug 24, 2022 | Common Stock | SSaleDisposed | −10,888 | $2.50F17 | −$27,220 | 497,741 | Indirect | |
| Aug 25, 2022 | Common Stock | SSaleDisposed | −8,394 | $2.42F18 | −$20,313.48 | 489,347 | Indirect | |
| Aug 26, 2022 | Common Stock | SSaleDisposed | −22,681 | $2.41F19 | −$54,661.21 | 466,666 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.5238 to $2.5463, which sale prices reflect the Stock Split. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (19) to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.433 to $2.5305, which sale prices reflect the Stock Split.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.4765 to $2.535, which sale prices reflect the Stock Split.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.574 to $2.685, which sale prices reflect the Stock Split.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.61 to $2.7285, which sale prices reflect the Stock Split.
Referenced by the price of 1 transaction in Table I.
- F8
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.715 to $2.7165, which sale prices reflect the Stock Split.
Referenced by the price of 1 transaction in Table I.
- F9
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.58 to $2.6955, which sale prices reflect the Stock Split.
Referenced by the price of 1 transaction in Table I.
- F10
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.85 to $3.03, which sale prices reflect the Stock Split.
Referenced by the price of 1 transaction in Table I.
- F11
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.85 to $2.964, which sale prices reflect the Stock Split.
Referenced by the price of 1 transaction in Table I.
- F12
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.8155 to $2.9685, which sale prices reflect the Stock Split.
Referenced by the price of 1 transaction in Table I.
- F13
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.775 to $2.9895, which sale prices reflect the Stock Split.
Referenced by the price of 1 transaction in Table I.
- F14
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.7015 to $2.7510, which sale prices reflect the Stock Split.
Referenced by the price of 1 transaction in Table I.
- F15
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.598 to $2.736, which sale prices reflect the Stock Split.
Referenced by the price of 1 transaction in Table I.
- F16
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.6175 to $2.6228, which sale prices reflect the Stock Split.
Referenced by the price of 1 transaction in Table I.
- F17
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.4405 to $2.535, which sale prices reflect the Stock Split.
Referenced by the price of 1 transaction in Table I.
- F18
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $2.4735, which sale prices reflect the Stock Split.
Referenced by the price of 1 transaction in Table I.
- F19
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $2.4495, which sale prices reflect the Stock Split.
Referenced by the price of 1 transaction in Table I.
Remarks
The aggregate of 180,523 shares sold from August 2, 2022 through August 26, 2022 (which share amount reflects the 1-for-15 reverse stock split effected August 26, 2022 (the "Stock Split")) are matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, with a purchase of shares by the Jack W. Schuler Living Trust that occurred on March 31, 2022. As each post-Stock Split per share price at which the 180,523 shares were sold is lower in each instance than the post-Stock Split per share price of the shares purchased on March 31, 2022, there are no profits to disgorge to the Issuer.